Control study of escitalopram and amitriptyline in treatment of depression
Wang Cuipeng
Abstract
Wang Cuipeng
Abstract
Objective: To compare the clinical efficacy and safety of escitalopram and amitriptyline in treatment of depression.Methods: Randomly divided fifty patients into two groups,the study group included 25 cases and took escitalopram orally,the control group included 25 cases and took amitriptyline orally,who were all obseved 6 weeks.Before and after 1,2,4,6 weeks of treatment,evaluation of clincal effects with Hamilton's depression scale(HAMD) and clinical global impression(CGI),evaluation of side effects with Asberg.Results: On the sixth weekend,the obvious effect rate was 96% in the study group,but that was 92% in the control group,which had no significant difference(P0.05).The total scores of Asberg in the study group were significant lower than that in the the control group(P0.01).Conclusion: On treating the patients with depression,the effects of escitalopram is equvalent with amitriptyline,but escitalopram is better than amitripty-line in safety and the compliance.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: To compare the clinical efficacy and safety of escitalopram and amitriptyline in treatment of depression.Methods: Randomly divided fifty patients into two groups,the study group included 25 cases and took escitalopram orally,the control group included 25 cases and took amitriptyline orally,who were all obseved 6 weeks.Before and after 1,2,4,6 weeks of treatment,evaluation of clincal effects with Hamilton's depression scale(HAMD) and clinical global impression(CGI),evaluation of side effects with Asberg.Results: On the sixth weekend,the obvious effect rate was 96% in the study group,but that was 92% in the control group,which had no significant difference(P0.05).The total scores of Asberg in the study group were significant lower than that in the the control group(P0.01).Conclusion: On treating the patients with depression,the effects of escitalopram is equvalent with amitriptyline,but escitalopram is better than amitripty-line in safety and the compliance.
Key concepts: Escitalopram, Amitriptyline, Medicine, Depression (economics), Hamd, Clinical Global Impression, Internal medicine, Clinical efficacy